PharmaInformatic´s Scientific Network
We have a strong background in ChemInformatics and BioInformatics, together with expertise in Information Technology and Artificial Intelligence (AI):
Rational Drug Design
Chemical Databases
Novel Descriptors
Molecular Modeling
Rule Based Docking
Chemical Similarity
Pharmacology & ADMET
3D Protein Structures
Sequence Analysis
Disease & Target-Databases
Protein Function & Interaction
Pharmacogenomics & SNPs
Enzymes & Metabolism
Data Preparation
Data Integration
Relational Databases
Object-Orientated Databases
Database Management
PACT-F
Prediction & Optimisation
Neural Networks
Decision Trees
Bayesian Learning
Data Mining & Text Mining
IMPACT-F
The largest knowledge base
on bioavailability worldwide.
An expert system
to predict oral bioavailability
in humans.
An expert system for finding
suitable
drug candidates.
An expert system for finding molecules with antibiotic activity.
An expert system for finding molecules with antiviral activity.
|
|
Founder and CEO of PharmaInformatic is Dr W. Boomgaarden. He has developed virtual screening and drug design software products which have been successfully used in the pharmaceutical world. Before he founded the company, he worked as a professor in bioInformatics in Emden, Germany. |
 |
 |
 |
 |
 |
|
|
|
© Copyright 2004-2021 PharmaInformatic Boomgaarden. All rights reserved. Site map Contact Terms of Use Imprint |
Evaluate
efficiency of drugs
before
advanced clinical trials:
==>
IMPACT-F
BIOAVAILABILITY
ESTIMATION
(more)
|
|
